GoodRx Holdings, Inc.GDRXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank44
3Y CAGR-7.9%
5Y CAGR-7.2%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-7.9%/yr
vs +43.2%/yr prior
5Y CAGR
-7.2%/yr
Consistent
Acceleration
-51.1pp
Decelerating
Percentile
P44
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$547.16M-19.3%
2024$678.26M-4.5%
2023$710.35M+1.5%
2022$699.74M+2.1%
2021$685.30M-14.0%
2020$796.83M+239.8%
2019$234.53M+41.1%
2018$166.24M+75.4%
2017$94.76M+35.1%
2016$70.14M-